Cargando…
Inhibition of phosphoenolpyruvate carboxykinase blocks lactate utilization and impairs tumor growth in colorectal cancer
BACKGROUND: Metabolic reprogramming is a key feature of malignant cells. While glucose is one of the primary substrates for malignant cells, cancer cells also display a remarkable metabolic flexibility. Depending on nutrient availability and requirements, cancer cells will utilize alternative fuel s...
Autores principales: | Montal, Emily D., Bhalla, Kavita, Dewi, Ruby E., Ruiz, Christian F., Haley, John A., Ropell, Ashley E., Gordon, Chris, Haley, John D., Girnun, Geoffrey D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6670241/ https://www.ncbi.nlm.nih.gov/pubmed/31388420 http://dx.doi.org/10.1186/s40170-019-0199-6 |
Ejemplares similares
-
Phosphoenolpyruvate carboxykinases as emerging targets in cancer therapy
por: Yu, Yong, et al.
Publicado: (2023) -
Kinetic and functional properties of human mitochondrial phosphoenolpyruvate carboxykinase
por: Escós, Miriam, et al.
Publicado: (2016) -
The requirement of phosphoenolpyruvate carboxykinase 1 for angiogenesis in vitro and in vivo
por: Yao, Jin, et al.
Publicado: (2022) -
Neddylation of phosphoenolpyruvate carboxykinase 1 controls glucose metabolism
por: Gonzalez-Rellan, María J., et al.
Publicado: (2023) -
Integrating multiple regulations on enzyme activity: the case of phosphoenolpyruvate carboxykinases
por: Rojas, Bruno E, et al.
Publicado: (2023)